Toxic exposure research program support services
Ended Awarded Last action
- Contract number
- HT942525F0255
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $196,538
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 99% obligated
- $197,965.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $76,327 | |
| Original award | $120,210 |
About this award
The Defense Health Agency awarded a delivery order to Leidos, Inc. (doing business as SAIC) valued at approximately $198K for toxic exposure research program support services and additional ad-hoc reviews under the Fiscal Year 2025 Toxic Exposures Research Program. The contract employs a cost-plus-fixed-fee pricing structure and will be performed in Frederick, Maryland, with an ultimate completion date of July 13, 2026. No set-aside designation was utilized for this award, reflecting Leidos' competitive capabilities in the open federal marketplace.
This delivery order supports the Defense Health Agency's mission to address health concerns among service members and military populations exposed to environmental and occupational hazards. The toxic exposure research program represents a critical initiative within the Department of Defense health portfolio, examining conditions and health outcomes related to various exposure scenarios. Leidos, a major technology and engineering solutions provider with extensive experience supporting federal medical research initiatives, brings relevant expertise through its established relationship with the Defense Health Agency and its broader portfolio of contracts supporting medical research in areas including traumatic brain injury, cancer, and rare disease investigation.
Quick answers
Who was awarded contract HT942525F0255?
HT942525F0255 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 14, 2025.
How much is contract HT942525F0255 worth?
The government has obligated $196,538 on HT942525F0255. Its current value, with exercised options, is $197,966.
Is contract HT942525F0255 an order under another contract?
Yes. HT942525F0255 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942525F0255 competed?
The extent of competition for HT942525F0255 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award